chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On the evening of 9/4/2014 at approx 8:30 pm, noticed that my 4 month old daughter felt slightly fevered.  I then gave my daughter some infant tylenol, but she threw up after I gave it to her. Since her pajamas were soiled from her vomit, I went to change her pajamas and noticed what appeared to be a purpura looking rash on her right side lower abdomen.  Concerned, took her to the emergency room.  The emergency room doctor called her rash purpura, and determined she also had a UTI. I informed them that I was concerned she was having a reaction to her vaccinations she had the previous day, but they would not even consider that.  Her symptoms included fever, vomiting and the rash. Hospital admitted her to do some more testing. All labs and tests came back normal. We were not happy with the lack of professional care received at Hospital, so we had her transferred to another Hospital.  She was hospitalized for a total of 6 days and never officially received a diagnosis or explanation of what caused this.  I feel very STRONGLY that this was an adverse affect of one if not all of her vaccines.
Pt called the dept and left message. Pt was contacted at 2:15pm of 04/07/2009, stated"03/26/2009 got injection in clinic, started to act out on Friday morning, forehead bumps and hives-like, itchy and irritationg with eyes swelling,later that day, spreaded out the whole face, but forehead mostly affected. Took Benadryl 25mg Q4 hr that day, eased off itch, bumps still there. Benadryl cream applied, soothing some. It took the whole week to get out of that. The following Friday, almost totally recovered. Now, no signs or symtoms, I am fine."
Arm soreness at vaccination site; This is a spontaneous report received from a non-contactable consumer (patient). A 66-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6201, expiry date unknown), via an unspecified route of administration, on 19Feb2021 09:15, at single dose, for COVID-19 immunization. Medical history included asthma and penicillin allergy. The patient was not pregnant at the time of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination and was not tested for COVID-19 since the vaccination. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the BNT162B2 vaccine. On 19Feb2021 at 11:00, the patient experienced arm soreness at vaccination site. Treatment included Aspirin. The outcome of the event was unknown. The reporter assessed the event as non-serious.  No follow-up attempts are needed. No further information is expected.
Intermittent sharp pain at the site of the injection, persisting for a couple of months past the injection date. Pain is not constant and might not be felt for several days and then randomly my arm will hurt for several hours - just at the spot of the injection. No shooting pain, no whole arm pain.
Since date of administration, arm has been sore, with pain. Describes pain as "10". Reports no redness, heat or swelling.
pt recv vax 8APR(7 & 15APR97 pt devel a varicella-like rash w/more than 300 lesions on face, back, trunk, legs & genitals;
Information has been received from a physician concerning an 8 year old white female who on 06-JUN-2000 was vaccinated with varicella virus vaccine live (Oka/Merck) (lot#). There was no concomitant medication. On 08-JUN-2007 the patient was diagnosed with varicella. No further sequel symptoms were reported. Subsequently, on 15-JUN-2007 the patient recovered from varicella. No further information is available.
my blood sugar spiked. had just had blood work done prior to first dose no sign of diabetes 2 days after 2nd shot started feel fatigue headache and urine increase went to doctor today i have type 2 diabetes.
Received AVA #1, had flu-like symptoms with cough, fever, felt like a really bad cold. When starting to get better, was given second AVA on Mar 23, coughing so severe hept her awake all night, tried lying on floors, bed, chairs to try to suppress cough. Deployed Mar 25th, severe cough, runny nose, mild fevers, using cold and cough syrup without effect. Seen by medic, given Tessalon perle, Sudafed, none helpful. Arrived overseas Apr 4, seen Apr 7 by MD, given Guifenisin, Levoquin. Cough relieved, but fatigue remained. Seen May 27, 04 for shortness of breath. Since that time SOB has continued and worsened, and additional symptoms now include headache on daily basis, mild fevers, short term memory loss that is particularly bothersome, body and muscle aches, and weight gain (from ususal wgt of 135-140 to now 165-180 lbs).
This spontaneous report was received from a 88 year old female patient regarding herself. On an unknown date in 2008, the patient was vaccinated with a dose of ZOSTAVAX (lot #, expiry not reported), subcutaneously. Concomitant therapies included GRALISE and CYMBALTA. On an unknown date in November 2012, the patient was diagnosed with the shingles after receiving the vaccine in 2008. She said it was on her left arm and elbow and left breast and shoulder. Patient received treatment with prescribed antivirals-the name not given. Patient sought medical attention. She stated she was following up with her physician. The outcome of shingles was reported as not recovered. Additional information has been requested.
PATIENT AND HUSBAND REPORTED TO THE PHARMACY AT APPROXIMATELY 08:00PM TO REPORT PATIENT WAS HAVING HEADACHE, LIGHT-HEADEDNESS AND DIFFICULTY SPEAKING. HUSBAND STATES THEY WAITED IN THE STORE AND SHOPPED FOR 15 MINUTES BEFORE LEAVING TO GO TO A WORK EVENT. THERE SHE BEGAN HAVING SYMPTOMS.
nausea; Body ache; high fever; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nausea), PAIN (Body ache) and PYREXIA (high fever) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 2 dosage form. On 06-Feb-2021, the patient experienced NAUSEA (nausea), PAIN (Body ache) and PYREXIA (high fever). At the time of the report, NAUSEA (nausea), PAIN (Body ache) and PYREXIA (high fever) outcome was unknown. Not Provided
5 yr shots given 02/07/05, noticed reaction on 2/8 evening. Left thigh red, hot to touch and swollen all the way to knee. Splotchy redness spread to entire thigh. Called nurse and said to apply warm compress and Motrin. Was better next day when came in office.
Pt received expired bivalent booster. Pt reports no side effects after receiving the vaccine.
Pfizer COVID-19 vaccine made him sick after the dose; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ILLNESS (non-serious), outcome "unknown", described as "Pfizer COVID-19 vaccine made him sick after the dose".  Additional information:Unknown caller reported that the Pfizer COVID-19 vaccine made him sick after the dose. He wants to know why the vaccine is killing people. He asked if we, Pfizer employees, are exempted from taking the product. He said that he is recording the call and asked why we are recording the call. He requested for a supervisor.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report as received from a healthcare professional refers to an unspecified number of patients. In approximately 2015 (reported as since 13-MAR-2015), the patients were vaccinated with doses of ROTATEQ lot # K010221, K011663, K016313 and lot # reported as K015816 (expiration date, dose, route and site of administrations were not reported) that were exposed to temperatures outside of the recommended range. No adverse effects had been observed or reported. Follow up information has been received from the medical assistant on 02-JUL-2015 concerning a patient of unknown age and gender who on 06-APR-2015 was vaccinated with an unknown dose of ROTATEQ (lot # K011663) (route defaulted as oral) that was 12 hours temperature excursion. This is one of several reports received from the same source. Additional information is not expected as all correspondence was received.
extreme fatigue 7+ days , headache 3 days, acute muscle spasm across upper body 4-5 days, congestion 2 days, shortness of breath 2 days
Lump, red, itchy, warm all at vaccine site, used benadryl spray, no improvement after 20 minutes
BRUISE APPEARANCE AROUND SITE OF INJECTION; LOSS OF APPETITE; CHILLS; FEVER; HEADACHE; FATIGUE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN) dose was not reported, administered on 15-MAR-2021 at right deltoid for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced bruise appearance around site of injection, loss of appetite, chills, fever, headache, and fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the chills, fever, bruise appearance around site of injection, headache, loss of appetite and fatigue was not reported. This report was non-serious. The case is associated with Product Quality Complaint number # 90000173359. The suspected product quality complaint has been confirmed to be voided (does not meet PQC criteria) based on the PQC evaluation/investigation performed.
Shortly After 3/10 vaccine: Short (1 minute) headache from base of skull to total head (growing then fading). Then on 4-15 ER visit and admission for stroke symptoms that day. TIA  diagnosis. Multinodular thyroid also diagnosed. By imaging .
In November of 2019, my bloodwork was all normal.  When I had bloodwork in April, it showed my red blood cells were clumping, but my anti-DSDNA was still normal.  By mid-May, all the Lupus tests were double the high normal accepted and cold agglutinen tests were positive, although I am not anemic.  I have had morning nausea ever since the shot and feel off balanced.  I think it has triggered a lupus flare because of its affect on T-cells and antibodies.  I am undergoing further testing and have an upcoming appointment with a rheumatologist.
Menveo brand by GlaxoSmithKline is given as the second dose. 17 year old male discharged from appointment in pediatrics. Nurse alert called to outside front lobby. Patient was found to be lying on ground with purse under his head and mother by his side. Per mother, as he left our clinic, he walked outdoors and verbalized that it was blurry and bright to see and passed out immediately. When nurse arrives, patient was found alert, oriented to place, person and time. Initial vital signs while supine at 1145 am, B/P 110/74, AHR 59, blood chemstix 85, pulse oximetry 99% on room air. He was closely monitored for the next 15 minutes outdoors then transferred back to the pediatric treatment room at noon via wheelchair. The primary care provider was notified of incident immediately. It was noted that he had received his meningococcal vaccine prior to leaving his appointment and had not had anything to eat or drink before his visit today.  He was monitored until 1230 pm as vital signs remained stable. He was also given apple juice, crackers and 24 ounces of water while being monitored. Dr. (PCP) evaluated him and  was cleared to be discharged home. Nurse accompanies him by walking him outside as mother had car pulled up and escorted to car. He denied any further symptoms upon discharge.
Headache, myalgias, sore throat, fatigue starting hours after injection. Supportive therapy, NSAID.
got really sick with the second installment; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (got really sick with the second installment) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Chemotherapy (For cancer for which patient was diagnosed with, before having the Moderna COVID-19 vaccine.) since an unknown date. Concurrent medical conditions included Cancer.   On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ILLNESS (got really sick with the second installment). At the time of the report, ILLNESS (got really sick with the second installment) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Jan-2022, Polymerase chain reaction: no antibodies for covid 19 were present. (Negative) No antibodies for COVID 19 were present, it was due to chemotherapy.         Concomitant medications were not provided by the reporter.  It was reported that patient took all the doses of the vaccine in the appropriate time frame, including the Moderna booster vaccine.  Treatment information was not provided.
All over body aches; Queasiness; This case was reported by a consumer via call center representative and described the occurrence of general body pain in a 63-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 12th November 2020, the patient received the 2nd dose of Shingrix (intramuscular) .5 ml. On 13th November 2020, 1 days after receiving Shingrix, the patient experienced general body pain and queasy. On an unknown date, the outcome of the general body pain and queasy were not recovered/not resolved.   The reporter considered the general body pain and queasy to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix in the left arm. vaccine on 12th November 2020 and on 13th November 2020, patient experienced all over body aches and queasiness.      The patient was asking if he was contagious to others. The reporter did not consent to follow up.
It aggravated my asthma around bedtime that night. The next few days I had mild cold/allergy like symptoms. 4/21 I woke up feeling like I had the flu and it progressively got worse throughout the day. I called the pharmacy and they told me to see a doctor to make sure I wasn't sick. Today, 4/22, I was tested for covid-19 and flu a and b and they were both negative. I'm still feeling under the weather. My symptoms have included: increased asthma like symptoms, increased allergy like symptoms such as increased sinus irritation, mucus, and sinus bleeding, fatigue, feeling feverish and achy without having an actual fever, irritation at bottom of throat that sometimes causes coughing, stiffness, slight dizziness/fogginess
period was delayed, expected it first week of January; This spontaneous case was reported by a consumer and describes the occurrence of MENSTRUATION DELAYED (period was delayed, expected it first week of January) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Pfizer (First dose (lot ER8733)) on 01-Apr-2021 and Pfizer (Second dose (lot ER8731)) on 22-Apr-2021. Past adverse reactions to the above products included No adverse event with Pfizer and Pfizer.    On 30-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MENSTRUATION DELAYED (period was delayed, expected it first week of January). At the time of the report, MENSTRUATION DELAYED (period was delayed, expected it first week of January) outcome was unknown.            The last period she had before taking the Moderna booster was on 05 Dec 2021, so she expected her period the first week of January. She didn't get her period until 21 Jan 2022.  No concomitant medication was reported. No treatment medication was reported.  Patient was not taking any oral contraceptives or other medications.
This case was reported by a nurse via out of hour services and described the occurrence of general body pain in a adult female patient who received SHINGRIX for prophylaxis. On 9th August 2018, the patient received the 2nd dose of SHINGRIX. On 10th August 2018, 1 days after receiving SHINGRIX, the patient experienced general body pain, fever and joint pain. The patient was treated with ibuprofen. On an unknown date, the outcome of the general body pain, fever and joint pain were not recovered/not resolved. It was unknown if the reporter considered the general body pain, fever and joint pain to be related to SHINGRIX. Additional details were provided as follows: This case was reported by nurse practitioner for herself. The age group was not reported but was selected as adult as per vaccine indication. On Thursday, 9th August 2018, the patient received 2nd dose of SHINGRIX. On 10th August 2018, the patient experienced body aches and joint aches. The patient was also reporting a fever of 100 degrees F. The patient took 800 mg of Ibuprofen with no effect alleviating her symptoms. At time of message, symptoms were not resolved. A VM was left on Friday, 10th August 2018, at 9:12 PM. The contact person filed the adverse reaction as discussed on the voice mail. He would call back later in the day to ask additional questions. There might be a follow up report as a result. This adverse events has been corrected by agent. The contact person attempted a second call back and the patient did not answer; only voicemail was left. The patient was given a number to reference, if she desires to call back.
Vials were initially stored in the fridge on 08-Jul-2022 and administered on 09-Aug-2022; HCP was not aware of any symptoms for any patient after the vaccine was given; Patient was administered with vaccine after 30-day use by date; This spontaneous case was reported by a physician assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient was administered with vaccine after 30-day use by date), PRODUCT STORAGE ERROR (Vials were initially stored in the fridge on 08-Jul-2022 and administered on 09-Aug-2022) and NO ADVERSE EVENT (HCP was not aware of any symptoms for any patient after the vaccine was given) in a 6-month-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AS1414B) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Aug-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 09-Aug-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient was administered with vaccine after 30-day use by date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vials were initially stored in the fridge on 08-Jul-2022 and administered on 09-Aug-2022) and NO ADVERSE EVENT (HCP was not aware of any symptoms for any patient after the vaccine was given). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient was administered with vaccine after 30-day use by date), PRODUCT STORAGE ERROR (Vials were initially stored in the fridge on 08-Jul-2022 and administered on 09-Aug-2022) and NO ADVERSE EVENT (HCP was not aware of any symptoms for any patient after the vaccine was given) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (HCP was not aware of any symptoms for any patient after the vaccine was given) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Patient was administered with vaccine after 30-day use by date) and PRODUCT STORAGE ERROR (Vials were initially stored in the fridge on 08-Jul-2022 and administered on 09-Aug-2022).    No concomitant medications were reported. It was reported that the vial had not undergone any temperature excursions. No treatment medications were reported.
High fever, confusion, waving hands in the air, body going tense seizure like movements.
HA, Body aches, fever, chills, dizzy, light headed, rash on face.  Took OTC Benadryl and symptoms improving
Light tingling of my tongue while waiting after vaccine.  I was given water and then waited additional time.  Seemed better so we left.  About 45 min to an hour after injection  I started getting a warm feeling in my chest.  It lasted about an hour. The next day in p.m. I was very tired and my arm hurt.  When I got ready for bed I noticed  that at the injection site it was red , a little swollen , itchy and painful.  The next day It was the same but more red.  I put ice on it throughout the day which helped some.
Morning after vaccine the patient developed fever, myalgias and then developed abdominal pain and vomiting. Presented to emergency department where he was noted to have elevated inflammatory markers, gallbladder thickening, and decreased EF in the 40s. Patient met criteria for MIS-C and was treated with IVIG and steroids. Case was reported to a federal agency.
COVID positive on 5/14/2020. Then had several negative tests. Received two doses of the Moderna vaccine on 1/4/2021 and 2/1/2021. Tested covid negative on 2/22/2021. Was retested as part of the protocol for her job on 2/26/2021, and tested positive. She was asymptomatic. Sequencing was not able to be performed. She then had two negative covid tests on 3/1/2021 and 3/2/2021 (all tests were PCR tests.) She has now completed her isolation period.
Next day fever, headache - 30 degrees C - took TYLENOL - Fever lasted one day - Headache lasted 2days.
Patient ran a fever immediately after vaccines, then broke out into a hives type rash 3 days later.
tested positive for COVID; tested positive for COVID; This is a spontaneous report from a contactable nurse (patient). A 64-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK5730, expiration date: 31Mar2021), via intramuscular on 21Dec2020 at 0.3 mL single in left deltoid for preventative. Medical history included she only had one kidney from 25Feb2020. There were no concomitant medications. It was reported that the patient was supposed (was scheduled) to get her second dose today (11Jan2021) but this past weekend she tested positive for COVID on 09Jan2021. The patient wanted to know if it would affect getting the second dose of the vaccine. The patient supposed to be quarantining right now and she was not symptomatic. On 09Jan2021 she found out she was positive for covid. The outcome of the event was unknown.; Sender's Comments: A causal association between reported event and suspect BNT162B2 cannot be excluded.